| Followers | 9 |
| Posts | 161 |
| Boards Moderated | 0 |
| Alias Born | 03/14/2019 |
Monday, April 15, 2024 9:42:46 AM
This company’s shares start recovering gradually after the high sales late in 2023, which were probably connected with taxes. In 2023, this company performed a rebranding, and now it is Fountayn.
https://www.fountayn.com/about
The sectors and industries where Fountayn operates are of interest (BioTech and others) as a lot of money is concentrated there! The company’s main product has positive reviews. Even former employees of DATATRAK/Fountayn share their positive opinions about the main product, yet criticizing the company management though. The latest financial report available (for 2022) shows that the company is facing some financial problems. However, in 2023, the company presented an interesting press release!
In this press release (May, 2023) the company shares the following information:
"The Fountayn rebrand launched January 2023, and since then the company has seen its highest level of new sales activity in over ten years. However, these activities will not fully impact revenue immediately and often will be spread out over the duration of the contracts."
https://www.otcmarkets.com/stock/DTRK/news/Datatrak-Reports-2022-Earnings?id=398709
P. S.: The company is expected to release a new financial report soon. It will be interesting to see it! Has the company managed to change anything for the better or was it just a PR campaign …
https://www.fountayn.com/about
The sectors and industries where Fountayn operates are of interest (BioTech and others) as a lot of money is concentrated there! The company’s main product has positive reviews. Even former employees of DATATRAK/Fountayn share their positive opinions about the main product, yet criticizing the company management though. The latest financial report available (for 2022) shows that the company is facing some financial problems. However, in 2023, the company presented an interesting press release!
In this press release (May, 2023) the company shares the following information:
"The Fountayn rebrand launched January 2023, and since then the company has seen its highest level of new sales activity in over ten years. However, these activities will not fully impact revenue immediately and often will be spread out over the duration of the contracts."
https://www.otcmarkets.com/stock/DTRK/news/Datatrak-Reports-2022-Earnings?id=398709
P. S.: The company is expected to release a new financial report soon. It will be interesting to see it! Has the company managed to change anything for the better or was it just a PR campaign …
Disclaimer: My posts are my opinion and not a recommendation/investment advice! Do your own DD!
Recent DTRK News
- Datatrak and TAILRD Heart Announce Collaboration to Advance Ai‑Driven Healthcare and Life Sciences Clinical Research • ACCESS Newswire • 03/16/2026 07:35:00 PM
- DATATRAK ePRO/eCOA Solution Expands Decentralized Trial Platform • ACCESS Newswire • 03/10/2026 07:40:00 PM
- DATATRAK Standalone eConsent Accelerates Clinical Trials • ACCESS Newswire • 02/26/2026 05:45:00 PM
- CRO Selects Datatrak eSource for $1,800,000 Contract • ACCESS Newswire • 11/11/2025 01:00:00 PM
